AMB-CHMINACA

AMB-CHMINACA
Legal status
Legal status	CA: Schedule II ; DE: NpSG (Industrial and scientific use only) ; UK: Under Psychoactive Substances Act ;
Identifiers
	IUPAC name methyl (2S)-2-{[1-(cyclohexylmethyl)indazole-3-carbonyl]amino}-3-methylbutanoate;
CAS Number	1863066-03-8(racemate);
PubChem CID	119026010;
ChemSpider	32055578;
UNII	OU56JJP891;
Chemical and physical data
Formula	C21H29N3O3
Molar mass	371.481 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O;
	InChI InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1; Key:CRGGXDSTBHQLKJ-SFHVURJKSA-N;

AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB₁ receptor and has been sold online as a designer drug.[2][3][4]

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]

Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.[6]

gollark: Lua strings are seemingly just bytestrings, but it has a UTF8 library...

gollark: Almost fulfilling a property is sometimes worse than not fulfilling it, because it lulls you into a fælse sense of security.

gollark: UTF-1024

gollark: That would be bad and would be more evidence that lyric bad.

gollark: Oh, WAL mode.

References

Akamatsu, Shigeki; Yoshida, Masashi (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28–32. doi:10.1002/jms.3722. PMID 26757069.
"MA-CHMINACA". Cayman Chemical. Retrieved 21 July 2015.
"MA-CHMINACA". Southern Association of Forensic Scientists. Archived from the original on 27 September 2015. Retrieved 21 July 2015.
Samuel D Banister; et al. (July 2016). "The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues". ACS Chemical Neuroscience. 7 (9): 1241–54. doi:10.1021/acschemneuro.6b00137. PMID 27421060.
"CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Archived from the original on 15 July 2015. Retrieved 21 July 2015.
"Sexton nya ämnen klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 18 January 2019.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Akamatsu, Shigeki; Yoshida, Masashi (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28–32. doi:10.1002/jms.3722. PMID 26757069.

[2] "MA-CHMINACA". Cayman Chemical. Retrieved 21 July 2015.

[3] "MA-CHMINACA". Southern Association of Forensic Scientists. Archived from the original on 27 September 2015. Retrieved 21 July 2015.

[4] Samuel D Banister; et al. (July 2016). "The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues". ACS Chemical Neuroscience. 7 (9): 1241–54. doi:10.1021/acschemneuro.6b00137. PMID 27421060.

[5] "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Archived from the original on 15 July 2015. Retrieved 21 July 2015.

[6] "Sexton nya ämnen klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 18 January 2019.

AMB-CHMINACA

Legal status

See also

References